Indoco Remedies Limited
INDOCO · NSE · ₹252 a share (close of 01 Oct 2026)
Available company data, source links and archived checks for Indoco Remedies Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 6.8%; Net profit was ₹65.44 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹468 cr | +6.8% | Net profit: ₹65 cr | — | 14.0% | Company filing source |
| Mar 2026 | Revenue: ₹476 cr | +21.9% | Net profit: ₹-24 cr | — | -5.0% | Company filing source |
| Dec 2025 | Revenue: ₹445 cr | — | Net profit: ₹-29 cr | — | -6.6% | Company filing source |
| Sep 2025 | Revenue: ₹485 cr | — | Net profit: ₹-9 cr | — | -1.9% | Company filing source |
| Jun 2025 | Revenue: ₹438 cr | +1.5% | Net profit: ₹-36 cr | -2097.3% | -8.3% | Company filing source |
| Mar 2025 | Revenue: ₹390 cr | — | Net profit: ₹-41 cr | — | -10.6% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
SPA HOLDINGS PVT LTD 19.9%SHANTERI INVESTMENT PVT LTD 17.2%KARE FAMILY PRIVATE TRUST 14.2%NIPPON LIFE INDIA TRUSTEE LTD A/C NIPPON INDIA SMALL CAP FUND 4.8%QUANT MUTUAL FUND QUANT SMALL CAP FUND 4.5%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- General Updates. Indoco Remedies Limited has informed the Exchange about intimation to shareholders holding shares in physical mode regarding mandatory furnishi…
29 Sep 2026 · document
- Acquisition. Indoco Remedies Limited has informed the Exchange about the incorporation of Wholly Owned subsidiary of the Company in the name and style of "Warre…
28 Sep 2026 · document
- Indoco Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015…
28 Sep 2026 · document
- General Updates. Indoco Remedies Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirem…
24 Sep 2026 · document
- Acquisition. Indoco Remedies Limited has informed the Exchange about Approval of the Committee of Executive DIrectors for incorporation of the wholly owned subs…
18 Sep 2026 · document
- Shareholders meeting. Indoco Remedies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 17, 2026. Further…
18 Sep 2026 · document
- Shareholders meeting. Indoco Remedies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 17, 2026…
17 Sep 2026 · document
- Updates. Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 UK MHRA inspection at Company''s manufacturi…
10 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time